Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1082

1.

Beating Heart Cells from Hair-Follicle-Associated Pluripotent (HAP) Stem Cells.

Hoffman RM, Amoh Y.

Methods Mol Biol. 2018;1842:241-254. doi: 10.1007/978-1-4939-8697-2_18.

PMID:
30196415
2.

Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma.

Kawaguchi K, Higuchi T, Li S, Han Q, Tan Y, Igarashi K, Zhao M, Miyake K, Kiyuna T, Miyake M, Ohshiro H, Sugisawa N, Zhang Z, Razmjooei S, Wangsiricharoen S, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Eckardt MA, Singh AS, Singh SR, Eilber FC, Unno M, Hoffman RM.

Biochem Biophys Res Commun. 2018 Sep 18;503(4):3086-3092. doi: 10.1016/j.bbrc.2018.08.097. Epub 2018 Aug 27.

PMID:
30166061
3.

Ultrasound Microbubble Delivery Targeting Intraplaque Neovascularization Inhibits Atherosclerotic Plaque in an APOE-deficient Mouse Model.

Yuan H, Hu H, Sun J, Shi M, Yu H, Li C, Sun YU, Yang Z, Hoffman RM.

In Vivo. 2018 Sep-Oct;32(5):1025-1032. doi: 10.21873/invivo.11342.

PMID:
30150423
4.

Imaging the interaction of αv integrin-GFP in osteosarcoma cells with RFP-expressing host stromal cells and tumor-scaffold collagen in the primary and metastatic tumor microenvironment.

Tome Y, Kiyuna T, Uehara F, Bouvet M, Tsuchiya H, Kanaya F, Hoffman RM.

J Cell Biochem. 2018 Aug 26. doi: 10.1002/jcb.27353. [Epub ahead of print]

PMID:
30145815
5.

Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model.

Kiyuna T, Tome Y, Murakami T, Kawaguchi K, Igarashi K, Miyake K, Miyake M, Li Y, Nelson SD, Dry SM, Singh AS, Russell TA, Elliott I, Singh SR, Kanaya F, Eilber FC, Hoffman RM.

BMC Cancer. 2018 Aug 20;18(1):840. doi: 10.1186/s12885-018-4703-0.

6.

White paper on microbial anti-cancer therapy and prevention.

Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, Gravekamp C, Gulley JL, Gunn H, Hoffman RM, Kaur B, Liu K, Lyerly HK, Marciscano AE, Moradian E, Ruppel S, Saltzman DA, Tattersall PJ, Thorne S, Vile RG, Zhang HH, Zhou S, McFadden G.

J Immunother Cancer. 2018 Aug 6;6(1):78. doi: 10.1186/s40425-018-0381-3.

7.

Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Lwin TM, Hoffman RM, Bouvet M.

J Surg Oncol. 2018 Aug;118(2):253-264. doi: 10.1002/jso.25150. Epub 2018 Aug 6. Review.

PMID:
30080930
8.

Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone.

Dondossola E, Alexander S, Holzapfel BM, Filippini S, Starbuck MW, Hoffman RM, Navone N, De-Juan-Pardo EM, Logothetis CJ, Hutmacher DW, Friedl P.

Sci Transl Med. 2018 Aug 1;10(452). pii: eaao5726. doi: 10.1126/scitranslmed.aao5726.

PMID:
30068572
9.

Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.

Nakamura M, Suetsugu A, Hasegawa K, Satake T, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2018 Aug;38(8):4417-4423. doi: 10.21873/anticanres.12743.

PMID:
30061205
10.

Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model.

Kiyuna T, Murakami T, Tome Y, Igarashi K, Kawaguchi K, Miyake K, Miyake M, Li Y, Nelson SD, Dry SM, Singh AS, Russell TA, Singh SR, Kanaya F, Eilber FC, Hoffman RM.

Tissue Cell. 2018 Aug;53:30-36. doi: 10.1016/j.tice.2018.05.010. Epub 2018 May 22.

PMID:
30060824
11.

Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models.

Kawaguchi K, Igarashi K, Miyake K, Kiyuna T, Miyake M, Singh AS, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Singh SR, Eilber FC, Hoffman RM.

J Drug Target. 2018 Aug 23:1-6. doi: 10.1080/1061186X.2018.1499748. [Epub ahead of print]

PMID:
30024282
12.

Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations.

Miyake K, Kawaguchi K, Miyake M, Zhao M, Kiyuna T, Igarashi K, Zhang Z, Murakami T, Li Y, Nelson SD, Bouvet M, Elliott I, Russell TA, Singh AS, Hiroshima Y, Momiyama M, Matsuyama R, Chishima T, Singh SR, Endo I, Eilber FC, Hoffman RM.

Heliyon. 2018 Jun 6;4(6):e00643. doi: 10.1016/j.heliyon.2018.e00643. eCollection 2018 Jun.

13.

A Simple Screening Tool May Help Identify High-Risk Children for Targeted HIV Testing in Malawian Inpatient Wards.

Moucheraud C, Chasweka D, Nyirenda M, Schooley A, Dovel K, Hoffman RM; EQUIP Innovations Team.

J Acquir Immune Defic Syndr. 2018 Jul 9. doi: 10.1097/QAI.0000000000001804. [Epub ahead of print]

PMID:
29995704
14.

Human Hair Follicle Associated-Pluripotent (hHAP) Stem Cells Differentiate to Cardiac Muscle Cells.

Hoffman RM.

Methods Mol Biol. 2018 Jul 11. doi: 10.1007/7651_2018_170. [Epub ahead of print]

PMID:
29992514
15.

Analysis of Anticancer Activity and Chemical Sensitization Effects of Dendropanax morbifera and Commersonia bartramia Extracts.

Kim S, Park SG, Song YJ, Park JK, Choi CH, Lee S, Hoffman RM.

Anticancer Res. 2018 Jul;38(7):3853-3861. doi: 10.21873/anticanres.12669.

PMID:
29970505
16.

Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.

Kawaguchi K, Miyake K, Zhao M, Kiyuna T, Igarashi K, Miyake M, Higuchi T, Oshiro H, Bouvet M, Unno M, Hoffman RM.

Cell Cycle. 2018 Sep 19:1-8. doi: 10.1080/15384101.2018.1480223. [Epub ahead of print]

PMID:
29963961
17.

In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization.

Millán-Gómez D, Dueñas S, Muñoz PLA, Camacho-Villegas T, Elosua C, Cabanillas-Bernal O, Escalante T, Perona A, Abia D, Drescher F, Fournier PGJ, Ramos MA, Mares RE, Paniagua-Solis J, Mata-Gonzalez T, Gonzalez-Canudas J, Hoffman RM, Licea-Navarro A, Sánchez-Campos N.

Oncotarget. 2018 Jun 15;9(46):28016-28029. doi: 10.18632/oncotarget.25549. eCollection 2018 Jun 15.

18.

Erratum: Publisher Correction: Is DNA methylation the new guardian of the genome?

Hoffman RM.

Mol Cytogenet. 2018 Jun 13;11:38. doi: 10.1186/s13039-018-0385-1. eCollection 2018.

19.

Impaired anticipatory vision and visuomotor coordination affects action planning and execution in children with hemiplegic cerebral palsy.

Surkar SM, Hoffman RM, Davies B, Harbourne R, Kurz MJ.

Res Dev Disabil. 2018 Sep;80:64-73. doi: 10.1016/j.ridd.2018.06.009. Epub 2018 Jun 22.

PMID:
29940386
20.

Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma.

Kiyuna T, Tome Y, Murakami T, Zhao M, Miyake K, Igarashi K, Kawaguchi K, Miyake M, Oshiro H, Higuchi T, Li Y, Dry SM, Nelson SD, Russell TA, Eckardt MA, Singh AS, Kanaya F, Eilber FC, Hoffman RM.

J Cell Biochem. 2018 Jun 22. doi: 10.1002/jcb.27183. [Epub ahead of print]

PMID:
29932244
21.

Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer.

Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Kiyuna T, Miyake M, Higuchi T, Oshiro H, Zhang Z, Razmjooei S, Wangsiricharoen S, Bouvet M, Singh SR, Unno M, Hoffman RM.

Cancer Lett. 2018 Sep 28;432:251-259. doi: 10.1016/j.canlet.2018.06.016. Epub 2018 Jun 18.

PMID:
29928962
22.

Adverse Pregnancy Outcomes among Women who Conceive on Antiretroviral Therapy.

Hoffman RM, Brummel SS, Britto P, Pilotto JH, Masheto G, Aurpibul L, Joao E, Purswani MU, Buschur S, Flore Pierre M, Coletti A, Chakhtoura N, Klingman KL, Currier JS; 1077HS PROMISE Team.

Clin Infect Dis. 2018 Jun 1. doi: 10.1093/cid/ciy471. [Epub ahead of print]

PMID:
29868833
23.

MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model.

Kawaguchi K, Igarashi K, Miyake K, Lwin TM, Miyake M, Kiyuna T, Hwang HK, Murakami T, Delong JC, Singh SR, Clary B, Bouvet M, Unno M, Hoffman RM.

Tissue Cell. 2018 Jun;52:124-128. doi: 10.1016/j.tice.2018.05.003. Epub 2018 May 5.

PMID:
29857821
24.

Moesin Up-regulation Is Associated with Enhanced Tumor Progression Imaged Non-invasively in an Orthotopic Mouse Model of Human Glioblastoma.

Wang Q, Lu X, Wang J, Yang Z, Hoffman RM, Wu X.

Anticancer Res. 2018 Jun;38(6):3267-3272. doi: 10.21873/anticanres.12591.

PMID:
29848673
25.

Implications of the New USPSTF Prostate Cancer Screening Recommendation-Attaining Equipoise.

Hoffman RM.

JAMA Intern Med. 2018 Jul 1;178(7):889-891. doi: 10.1001/jamainternmed.2018.1982. No abstract available.

PMID:
29801041
26.

The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.

Lwin TM, Hoffman RM, Bouvet M.

Expert Rev Anticancer Ther. 2018 Jul;18(7):651-662. doi: 10.1080/14737140.2018.1477593. Epub 2018 May 28.

PMID:
29768067
27.

Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy.

Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Li Y, Nelson SD, Dry SM, Singh AS, Elliott IA, Russell TA, Eckardt MA, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM.

J Cell Biochem. 2018 Aug;119(8):6598-6603. doi: 10.1002/jcb.26792. Epub 2018 May 8.

PMID:
29737543
28.

Exploiting methionine restriction for cancer treatment.

Chaturvedi S, Hoffman RM, Bertino JR.

Biochem Pharmacol. 2018 Aug;154:170-173. doi: 10.1016/j.bcp.2018.05.003. Epub 2018 May 4. Review.

PMID:
29733806
29.

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.

Igarashi K, Kawaguchi K, Li S, Han Q, Tan Y, Gainor E, Kiyuna T, Miyake K, Miyake M, Higuchi T, Oshiro H, Singh AS, Eckardt MA, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM.

Oncotarget. 2018 Apr 10;9(27):19263-19272. doi: 10.18632/oncotarget.24996. eCollection 2018 Apr 10.

30.

Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting S. typhimurium A1-R is superior to first-line chemotherapy.

Miyake K, Kiyuna T, Miyake M, Kawaguchi K, Yoon SN, Zhang Z, Igarashi K, Razmjooei S, Wangsiricharoen S, Murakami T, Li Y, Nelson SD, Russell TA, Singh AS, Hiroshima Y, Momiyama M, Matsuyama R, Chishima T, Singh SR, Endo I, Eilber FC, Hoffman RM.

Signal Transduct Target Ther. 2018 Apr 27;3:12. doi: 10.1038/s41392-018-0016-7. eCollection 2018.

31.

The complicated 'Yes': Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors.

Seaman AT, Dukes K, Hoffman RM, Christensen AJ, Kendell N, Sussman AL, Veléz-Bermúdez M, Volk RJ, Pagedar NA.

Patient Educ Couns. 2018 Oct;101(10):1741-1747. doi: 10.1016/j.pec.2018.04.012. Epub 2018 Apr 22.

PMID:
29709410
32.

Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.

Rough K, Seage GR 3rd, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Currier JS, Hoffman RM, Barr E, Shapiro DE, Patel K; PHACS and the IMPAACT P1025 Study Teams.

N Engl J Med. 2018 Apr 26;378(17):1593-1603. doi: 10.1056/NEJMoa1701666.

PMID:
29694825
33.

RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.

Sato K, Mori R, Hiroshima Y, Oba MS, Matsuyama R, Bouvet M, Hoffman RM, Endo I.

J Surg Res. 2018 Jun;226:122-130. doi: 10.1016/j.jss.2017.11.009. Epub 2018 Feb 22.

PMID:
29661277
34.

Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Lwin TM, Higuchi T, Kiyuna T, Miyake M, Oshiro H, Bouvet M, Unno M, Hoffman RM.

Cell Cycle. 2018;17(7):868-873. doi: 10.1080/15384101.2018.1445907. Epub 2018 May 21.

PMID:
29623758
35.

Differential Organ-targeting and Cellular Characteristics of Metastatic Human Pancreatic Cancer Cell Lines in Mouse Models.

Satake T, Suetsugu A, Nakamura M, Hasegawa K, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2018 Apr;38(4):1927-1935.

PMID:
29599308
36.

Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer via the Wnt/Beta-Catenin Signaling Pathway in an Orthotopic Mouse Model.

Wang W, Li Y, Chen Y, Chen H, Zhu P, Xu M, Wang H, Wu M, Yang Z, Hoffman RM, Gu Y.

Anticancer Res. 2018 Apr;38(4):1917-1925.

PMID:
29599307
37.

Visualizing the Tumor Microenvironment by Color-coded Imaging in Orthotopic Mouse Models of Cancer.

Suetsugu A, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2018 Apr;38(4):1847-1857. Review.

PMID:
29599301
38.

Hand-Arm Bimanual Intensive Therapy Improves Prefrontal Cortex Activation in Children With Hemiplegic Cerebral Palsy.

Surkar SM, Hoffman RM, Willett S, Flegle J, Harbourne R, Kurz MJ.

Pediatr Phys Ther. 2018 Apr;30(2):93-100. doi: 10.1097/PEP.0000000000000486.

PMID:
29578992
39.

Imaging the Governing Step of Metastasis in Gelfoam® Histoculture.

Hoffman RM, Chishima T.

Methods Mol Biol. 2018;1760:215-220. doi: 10.1007/978-1-4939-7745-1_20.

PMID:
29572807
40.

Comparison of "Dimensionality" of Cancer Cell Culture in Gelfoam® Histoculture and Matrigel.

Tome Y, Uehara F, Kanaya F, Hoffman RM.

Methods Mol Biol. 2018;1760:205-214. doi: 10.1007/978-1-4939-7745-1_19.

PMID:
29572806
41.

Imaging DNA Repair After UV Irradiation Damage of Cancer Cells in Gelfoam® Histoculture.

Miwa S, Hoffman RM.

Methods Mol Biol. 2018;1760:199-203. doi: 10.1007/978-1-4939-7745-1_18.

PMID:
29572805
42.

Nerve Growth and Interaction in Gelfoam® Histoculture: A Nervous System Organoid.

Hoffman RM, Mii S, Duong J, Amoh Y.

Methods Mol Biol. 2018;1760:163-186. doi: 10.1007/978-1-4939-7745-1_16.

PMID:
29572803
43.

Hair Follicle-Associated Pluripotent (HAP) Stem Cells in Gelfoam® Histoculture for Use in Spinal Cord Repair.

Liu F, Hoffman RM.

Methods Mol Biol. 2018;1760:145-162. doi: 10.1007/978-1-4939-7745-1_15.

PMID:
29572802
44.

Hair-Shaft Growth in Gelfoam® Histoculture of Skin and Isolated Hair Follicles.

Hoffman RM, Li L, Cao W.

Methods Mol Biol. 2018;1760:133-144. doi: 10.1007/978-1-4939-7745-1_14.

PMID:
29572801
45.

Methionine Dependency Determination of Human Patient Tumors in Gelfoam® Histoculture.

Hoffman RM.

Methods Mol Biol. 2018;1760:125-131. doi: 10.1007/978-1-4939-7745-1_13.

PMID:
29572800
46.

In Vivo-Like Cell-Cycle Phase Distribution of Cancer Cells in Gelfoam® Histoculture Observed in Real Time by FUCCI Imaging.

Hoffman RM, Yano S.

Methods Mol Biol. 2018;1760:109-123. doi: 10.1007/978-1-4939-7745-1_12.

PMID:
29572799
47.

Clinical Usefulness of the Histoculture Drug Response Assay for Prostate Cancer and Benign Prostate Hypertrophy (BPH).

Hoffman RM.

Methods Mol Biol. 2018;1760:101-107. doi: 10.1007/978-1-4939-7745-1_11.

PMID:
29572798
48.

Clinical Usefulness of the Histoculture Drug Response Assay for Breast Cancer.

Hoffman RM, Tanino H.

Methods Mol Biol. 2018;1760:93-100. doi: 10.1007/978-1-4939-7745-1_10.

PMID:
29572797
49.

Clinical Correlation of the Histoculture Drug Response Assay for Head and Neck Cancer.

Hoffman RM.

Methods Mol Biol. 2018;1760:83-92. doi: 10.1007/978-1-4939-7745-1_9.

PMID:
29572796
50.

Prospective Clinical Correlation of the Histoculture Drug Response Assay for Ovarian Cancer.

Hoffman RM, Jung PS, Kim MB, Nam JH.

Methods Mol Biol. 2018;1760:73-81. doi: 10.1007/978-1-4939-7745-1_8.

PMID:
29572795

Supplemental Content

Loading ...
Support Center